SCHEMBL6153618

SCHEMBL6153618

CCN(CC)CCOCc1ccccc1CCC(=O)C(=Cc1c(Cl)cccc1Cl)C(=O)OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDYL Q9Y232 1/20 0.39
KDM4E B2RXH2 5/20 0.38
HRH3 Q9Y5N1 1/20 0.36
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
SCN1A P35498 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
RORC P51449 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CHRM2 P08172 5/20 0.32
CHRM1 P11229 4/20 0.32
SLC22A1 O15245 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
THRB P10828 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152350 0.82 HPGD (0.39) KDM4EHRH3SMN1; SMN2LMNACYP1A2
SCHEMBL6152947 0.81 PLAAT3 (0.34)
SCHEMBL6153271 0.81 PLAAT3 (0.34)
SCHEMBL6161539 0.80 PLAAT3 (0.37) SMN1; SMN2ALDH1A1LMNA
SCHEMBL6161533 0.80 PLAAT3 (0.37) SMN1; SMN2ALDH1A1LMNA
SCHEMBL6153048 0.79 HPGD (0.34)
SCHEMBL6153049 0.79 HPGD (0.34)
SCHEMBL6153056 0.77 BACE1 (0.40) ALDH1A1LMNATSHRHTT
SCHEMBL6153057 0.77 BACE1 (0.40) ALDH1A1LMNATSHRHTT
SCHEMBL6153623 0.75 KDM4E (0.43) CDYLKDM4EHRH3BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307449-B1 1,4-DIHYDROPYRIDINES AS BRADYKININ ANTAGONISTS PFIZER PHARMA (JP) 2005-12-07 EP disclosed
US-6653313-B2 For treatment and prevention of inflammation, asthma, allergic rhinitis, pain and other disorders WARNER-LAMBERT COMPANY LLC 2003-11-25 US disclosed